(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

COVANCE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

COVANCE

ST13

US500000086567126

Class

9, 16, 31, 35, 36, 42, 44, 45

Filing

86567126

Registration

4897520

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

28

Latest update

02/09/2025

Trademark type

Word

Nice classes

9, 16, 31, 35, 36, 42, 44, 45

Filing date

03/17/2015

Registration date

02/09/2016

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

11/04/2021

Last transaction

02/09/2025

Responsible office

United States Patent and Trademark Office

Status code

705

Official register

Principal Register

First use anywhere

1996-11-00

First use in commerce

1996-11-00

Drawing code

4

Owner type

03

Owner location

PRINCETON, NJ

Examiner

SPARACINO, MARK

Law office

L30

Holders and representatives

Holders

LABCORP DRUG DEVELOPMENT INC.
Covance Inc.

Representatives

William M. Bryner Kilpatrick Townsend & Stockton LLP

Technical classification

Nice Classes

Class 9Class 16Class 31Class 35Class 36Class 42Class 44Class 45

Vienna Codes

No Vienna codes available.

Goods and services

Class 9

Downloadable electronic publicationsbookspamphletsarticlestechnical manualsinstructional and teaching materialsreports in the fields of research and development of pharmaceuticalmedical devicesbiotechnologybiochemicals

Class 16

Printed matterbookspamphletsarticlestechnical manualsinstructional and teaching materialsreports in the fields of research and development of pharmaceuticalsmedical devicesbiotechnologybiochemicals

Class 31

Live animals; live laboratory animals

Class 35

Business consultancy services; business management consultancy and advisory services; consultancy and advisory services in the field of business strategy; marketing services; regulatory submission managementassisting others in preparing and filing applications with governmental regulatory bodies for approval of new drugs and medical devices; economic forecasting and analysis; market research; business consulting services in the field of commercialization of pharmaceuticalsmedical devicesbiotechnologybiochemicals; business management servicesforecasting drug supplies for clinical trials; business management servicesrecruiting patients and volunteers for clinical trials; business administration of patient reimbursement programs; project management services for others for business purposes in the field of research and development of pharmaceuticalsmedical devicesbiotechnologybiochemicals; database management; business information services; business data analysis; business advice and commercial information

Class 36

Providing a database featuring information and statistics about patient reimbursement and insurance coverage for pharmaceuticals and medical devices; financial administration of patient reimbursement programs

Class 42

Scientific research and development; pharmaceutical drug development and testing services; research and development of pharmaceuticalsmedical devicesbiotechnologybiochemicals; medical and scientific researchdesigningorganizingconductingmonitoringmanaging clinical and non-clinical trials and studies on pharmaceuticals and medical devices for others; scientific consulting services for others in the field of clinical and non-clinical trials and studies on pharmaceuticals and medical devices; collectioncalibrationanalysis and reporting of medical and scientific research data in connection with clinical and non-clinical trials and studies on pharmaceuticals and medical devices; scientific laboratory services; scientific laboratory servicesformulating and bioprocessing pharmaceuticals; rental of laboratory apparatus and instruments; operating and maintaining a biorepository for medical and scientific research purposes; scientific research and analysis in the fields of bioinformaticsbiomarkersgenomicsproteomicsgenotypinggenetic profiling; custom design and development of chemical reagents and biochemical assays; medical laboratory services in the field of pathology; testing of laboratory animals for scientific research purposes; computer hardware and software design; developmentupdating and maintenance of software and databases; design and development of software for use in conducting animal and biological research in non-clinical pharmaceutical and medical device and development studies; providing online computer databases in the fields of research and development of pharmaceuticalsmedical devicesbiotechnologybiochemicals; data mining; providing a website featuring technology enabling users to remotely trackmonitoranalyzegenerate reports with information and statistics from clinical and non-clinical trials and studies on pharmaceuticals and medical devices; food safety testing and consultation related thereto; scientific research and analysis in the fields of food safetyfood packagingnutritional chemistry; scientific research and analysis in the field of pharmacology; advisory services in the field of pharmaceutical drug developmentselecting animal and biological research models for use in testing drugs; advisory services in the field of pharmaceutical drug developmentselecting biomarkers for use in testing drugs; lead candidate drug optimization servicesscientific research in the field of identifying compounds for drug development; providing medical and scientific information in the fields of biochemistrypharmaceuticals and clinical trials; providing online non-downloadable software for trackingmonitoringanalyzinggenerating and reporting information and statistics about patient reimbursement and insurance coverage for pharmaceuticals and medical devices

Class 44

Medical services in the fields of pathologypharmacologyimmunology; medical and psychological counseling; providing medical information and advice in the fields of pathologypharmacologyimmunology; collectionorganizationanalysisreporting of medical data in connection with clinical and non-clinical trials and studies on pharmaceuticals and medical devices

Class 45

Regulatory compliance consulting in the fields of pharmaceuticals and medical devices; regulatory compliance consulting in the field of obtaining government authorization to market pharmaceuticals and medical devices; regulatory compliance consulting in the field of food safety and nutritional labeling; providing information and advisory services about regulatory compliance in the fields of pharmaceuticalsmedical devicesfood safetynutritional labeling

Publications

History of USPTO decisions and trademark events.

28 publications found

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

02/09/2025

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

09/07/2022

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

11/04/2021

C15P

REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

11/04/2021

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

11/04/2021

E815

TEAS SECTION 8 & 15 RECEIVED

07/30/2021

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

02/09/2021

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

09/20/2018

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

09/20/2018

R.PR

REGISTERED-PRINCIPAL REGISTER

02/09/2016

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

11/24/2015

PUBO

PUBLISHED FOR OPPOSITION

11/24/2015

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

11/04/2015

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

10/16/2015

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/07/2015

DOCK

ASSIGNED TO EXAMINER

10/07/2015

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

09/15/2015

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/15/2015

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

09/15/2015

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

06/23/2015

GNRT

NON-FINAL ACTION E-MAILED

06/23/2015

CNRT

NON-FINAL ACTION WRITTEN

06/23/2015

DOCK

ASSIGNED TO EXAMINER

06/19/2015

AMPX

PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED

04/06/2015

ALIE

ASSIGNED TO LIE

04/06/2015

PARI

TEAS VOLUNTARY AMENDMENT RECEIVED

03/30/2015

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

03/26/2015

NWAP

NEW APPLICATION ENTERED

03/20/2015

Continuous trademark protection

Get notified about every new filing that threatens COVANCE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.